Concepts (198)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sarcoma, Alveolar Soft Part | 2 | 2018 | 11 | 0.860 |
Why?
|
| Consultants | 1 | 2021 | 11 | 0.730 |
Why?
|
| Pathology, Surgical | 1 | 2021 | 21 | 0.730 |
Why?
|
| Biopsy, Fine-Needle | 3 | 2022 | 119 | 0.690 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2018 | 37 | 0.600 |
Why?
|
| Alagille Syndrome | 3 | 2025 | 48 | 0.570 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2018 | 129 | 0.520 |
Why?
|
| Strongylida Infections | 1 | 2016 | 15 | 0.520 |
Why?
|
| Antigens, CD | 1 | 2018 | 437 | 0.510 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2016 | 138 | 0.490 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2015 | 57 | 0.450 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2015 | 64 | 0.450 |
Why?
|
| Polyps | 1 | 2015 | 43 | 0.450 |
Why?
|
| Peritoneal Neoplasms | 1 | 2015 | 57 | 0.440 |
Why?
|
| Endometrial Neoplasms | 1 | 2015 | 112 | 0.420 |
Why?
|
| Colorectal Neoplasms | 4 | 2025 | 637 | 0.410 |
Why?
|
| Adenocarcinoma, Clear Cell | 1 | 2012 | 26 | 0.380 |
Why?
|
| Lipoma | 1 | 2011 | 26 | 0.360 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2011 | 44 | 0.360 |
Why?
|
| Cicatrix | 1 | 2012 | 124 | 0.350 |
Why?
|
| Liver | 3 | 2025 | 1806 | 0.350 |
Why?
|
| Ulcer | 1 | 2010 | 50 | 0.320 |
Why?
|
| Endometriosis | 1 | 2012 | 174 | 0.310 |
Why?
|
| Cesarean Section | 1 | 2012 | 407 | 0.300 |
Why?
|
| Testicular Neoplasms | 1 | 2010 | 131 | 0.300 |
Why?
|
| Colonic Neoplasms | 1 | 2011 | 264 | 0.290 |
Why?
|
| Population Surveillance | 2 | 2022 | 415 | 0.290 |
Why?
|
| Paragonimiasis | 1 | 2008 | 1 | 0.290 |
Why?
|
| Paragonimus | 1 | 2008 | 1 | 0.290 |
Why?
|
| Lung Diseases, Parasitic | 1 | 2008 | 13 | 0.280 |
Why?
|
| Biopsy, Needle | 1 | 2008 | 234 | 0.270 |
Why?
|
| Diagnosis, Differential | 5 | 2018 | 1966 | 0.260 |
Why?
|
| Angiolymphoid Hyperplasia with Eosinophilia | 1 | 2005 | 4 | 0.240 |
Why?
|
| Ear Neoplasms | 1 | 2005 | 14 | 0.240 |
Why?
|
| SOXC Transcription Factors | 1 | 2025 | 12 | 0.230 |
Why?
|
| Asphyxia | 1 | 2005 | 14 | 0.230 |
Why?
|
| Oropharynx | 1 | 2005 | 36 | 0.230 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2005 | 66 | 0.230 |
Why?
|
| Androgen Receptor Antagonists | 1 | 2025 | 41 | 0.230 |
Why?
|
| Fructose | 1 | 2025 | 62 | 0.230 |
Why?
|
| Skin Neoplasms | 1 | 2012 | 897 | 0.220 |
Why?
|
| Eosinophils | 1 | 2005 | 122 | 0.220 |
Why?
|
| Head and Neck Neoplasms | 1 | 2010 | 615 | 0.220 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 1 | 2025 | 94 | 0.210 |
Why?
|
| Foreign Bodies | 1 | 2005 | 110 | 0.210 |
Why?
|
| Dependovirus | 1 | 2025 | 154 | 0.210 |
Why?
|
| SOX9 Transcription Factor | 2 | 2025 | 86 | 0.210 |
Why?
|
| Humans | 30 | 2025 | 132105 | 0.200 |
Why?
|
| Artificial Intelligence | 3 | 2024 | 297 | 0.200 |
Why?
|
| Glycosyltransferases | 1 | 2023 | 27 | 0.200 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2023 | 79 | 0.190 |
Why?
|
| Pyrazoles | 1 | 2025 | 330 | 0.190 |
Why?
|
| Meningioma | 1 | 2024 | 141 | 0.180 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2022 | 65 | 0.180 |
Why?
|
| Pathologists | 1 | 2021 | 30 | 0.180 |
Why?
|
| Meningeal Neoplasms | 1 | 2024 | 216 | 0.180 |
Why?
|
| Jagged-1 Protein | 4 | 2025 | 54 | 0.180 |
Why?
|
| Middle Aged | 10 | 2025 | 28936 | 0.180 |
Why?
|
| Coccidioidomycosis | 1 | 2021 | 12 | 0.180 |
Why?
|
| Gastric Outlet Obstruction | 1 | 2021 | 15 | 0.180 |
Why?
|
| Glucose | 1 | 2025 | 878 | 0.170 |
Why?
|
| Airway Obstruction | 2 | 2017 | 169 | 0.170 |
Why?
|
| Glucosyltransferases | 2 | 2023 | 50 | 0.170 |
Why?
|
| Genetic Therapy | 1 | 2025 | 720 | 0.170 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2022 | 246 | 0.160 |
Why?
|
| Postoperative Complications | 1 | 2012 | 3146 | 0.160 |
Why?
|
| User-Computer Interface | 1 | 2001 | 168 | 0.160 |
Why?
|
| Stomach | 1 | 2022 | 273 | 0.160 |
Why?
|
| Triage | 1 | 2001 | 148 | 0.160 |
Why?
|
| Epigenesis, Genetic | 1 | 2025 | 757 | 0.160 |
Why?
|
| Calcium-Binding Proteins | 2 | 2023 | 333 | 0.150 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2023 | 295 | 0.150 |
Why?
|
| Precancerous Conditions | 1 | 2022 | 278 | 0.150 |
Why?
|
| Kidney Neoplasms | 1 | 2022 | 454 | 0.140 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2001 | 203 | 0.140 |
Why?
|
| DNA Methylation | 1 | 2025 | 1130 | 0.140 |
Why?
|
| Exophthalmos | 1 | 2018 | 30 | 0.140 |
Why?
|
| Internet | 1 | 2001 | 405 | 0.140 |
Why?
|
| Granulation Tissue | 1 | 2017 | 13 | 0.140 |
Why?
|
| Referral and Consultation | 1 | 2021 | 569 | 0.140 |
Why?
|
| Orbital Neoplasms | 1 | 2018 | 48 | 0.130 |
Why?
|
| Heterozygote | 2 | 2020 | 716 | 0.130 |
Why?
|
| Tracheotomy | 1 | 2017 | 36 | 0.130 |
Why?
|
| Neuroendocrine Tumors | 1 | 2018 | 58 | 0.130 |
Why?
|
| Orbit | 1 | 2018 | 84 | 0.130 |
Why?
|
| Strongylida | 1 | 2016 | 1 | 0.130 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2018 | 775 | 0.130 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2022 | 764 | 0.130 |
Why?
|
| Cerebrospinal Fluid | 1 | 2016 | 98 | 0.130 |
Why?
|
| Pancreatic Neoplasms | 1 | 2022 | 728 | 0.130 |
Why?
|
| Male | 11 | 2025 | 64918 | 0.120 |
Why?
|
| Bile Duct Diseases | 1 | 2015 | 17 | 0.120 |
Why?
|
| Stomach Neoplasms | 1 | 2022 | 566 | 0.120 |
Why?
|
| Adult | 8 | 2025 | 31557 | 0.120 |
Why?
|
| Fallopian Tube Neoplasms | 1 | 2015 | 14 | 0.120 |
Why?
|
| Immunohistochemistry | 1 | 2018 | 1723 | 0.110 |
Why?
|
| Neoplasm Grading | 1 | 2015 | 303 | 0.110 |
Why?
|
| Gene Silencing | 2 | 2025 | 240 | 0.100 |
Why?
|
| Mediastinitis | 1 | 2012 | 16 | 0.100 |
Why?
|
| Sclerosis | 1 | 2012 | 38 | 0.100 |
Why?
|
| Animals | 7 | 2025 | 34953 | 0.100 |
Why?
|
| Intestinal Diseases | 1 | 2013 | 76 | 0.100 |
Why?
|
| Membrane Proteins | 2 | 2023 | 1597 | 0.100 |
Why?
|
| Amyloidosis | 1 | 2013 | 73 | 0.100 |
Why?
|
| Neoplasm Metastasis | 2 | 2025 | 725 | 0.100 |
Why?
|
| Gene Deletion | 1 | 2015 | 795 | 0.100 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2018 | 1305 | 0.090 |
Why?
|
| Female | 9 | 2025 | 70680 | 0.090 |
Why?
|
| Surveys and Questionnaires | 1 | 2021 | 3982 | 0.090 |
Why?
|
| Intestine, Small | 1 | 2013 | 309 | 0.090 |
Why?
|
| Ovarian Neoplasms | 1 | 2015 | 463 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2018 | 2171 | 0.080 |
Why?
|
| Myxoma | 1 | 2010 | 29 | 0.080 |
Why?
|
| Serrate-Jagged Proteins | 2 | 2023 | 37 | 0.080 |
Why?
|
| Breast Neoplasms | 1 | 2022 | 2683 | 0.080 |
Why?
|
| Heart Neoplasms | 1 | 2010 | 105 | 0.080 |
Why?
|
| Coronary Disease | 1 | 2012 | 683 | 0.070 |
Why?
|
| Ovum | 1 | 2008 | 16 | 0.070 |
Why?
|
| Mice | 5 | 2025 | 18566 | 0.070 |
Why?
|
| Biomarkers, Tumor | 2 | 2025 | 1683 | 0.060 |
Why?
|
| Keratosis | 1 | 2005 | 17 | 0.060 |
Why?
|
| Inhalation | 1 | 2005 | 8 | 0.060 |
Why?
|
| NAD | 1 | 2025 | 52 | 0.060 |
Why?
|
| Antigens, CD34 | 1 | 2005 | 109 | 0.060 |
Why?
|
| Arteriovenous Malformations | 1 | 2005 | 48 | 0.060 |
Why?
|
| Neurilemmoma | 1 | 2005 | 47 | 0.060 |
Why?
|
| Glycolysis | 1 | 2025 | 165 | 0.060 |
Why?
|
| Echocardiography | 1 | 2010 | 1125 | 0.050 |
Why?
|
| Phenotype | 2 | 2025 | 4541 | 0.050 |
Why?
|
| Biopsy | 2 | 2022 | 1290 | 0.050 |
Why?
|
| Fatal Outcome | 1 | 2005 | 377 | 0.050 |
Why?
|
| Mitotic Index | 1 | 2024 | 17 | 0.050 |
Why?
|
| Trachea | 1 | 2005 | 210 | 0.050 |
Why?
|
| Age of Onset | 1 | 2025 | 626 | 0.050 |
Why?
|
| Mitosis | 1 | 2024 | 201 | 0.050 |
Why?
|
| Radiography | 1 | 2005 | 818 | 0.050 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2023 | 105 | 0.050 |
Why?
|
| MutS Homolog 2 Protein | 1 | 2022 | 39 | 0.050 |
Why?
|
| MutL Protein Homolog 1 | 1 | 2022 | 52 | 0.050 |
Why?
|
| DNA Mismatch Repair | 1 | 2022 | 54 | 0.050 |
Why?
|
| Receptors, Androgen | 1 | 2025 | 410 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2025 | 4694 | 0.050 |
Why?
|
| Cell Movement | 1 | 2025 | 891 | 0.050 |
Why?
|
| Incidence | 2 | 2022 | 3365 | 0.050 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2022 | 74 | 0.050 |
Why?
|
| Pancreas | 1 | 2022 | 222 | 0.050 |
Why?
|
| Genetic Vectors | 1 | 2025 | 927 | 0.040 |
Why?
|
| Expert Systems | 1 | 2001 | 16 | 0.040 |
Why?
|
| Cholestasis | 1 | 2023 | 157 | 0.040 |
Why?
|
| Metaplasia | 1 | 2022 | 217 | 0.040 |
Why?
|
| Texas | 2 | 2022 | 3630 | 0.040 |
Why?
|
| Aged | 3 | 2025 | 21413 | 0.040 |
Why?
|
| Germ-Line Mutation | 1 | 2022 | 368 | 0.040 |
Why?
|
| Bile Ducts | 1 | 2020 | 54 | 0.040 |
Why?
|
| Cell Transdifferentiation | 1 | 2020 | 61 | 0.040 |
Why?
|
| Child | 3 | 2022 | 25758 | 0.040 |
Why?
|
| Risk | 1 | 2001 | 761 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2020 | 4764 | 0.040 |
Why?
|
| Hepatocytes | 1 | 2020 | 241 | 0.040 |
Why?
|
| Receptors, Notch | 1 | 2020 | 213 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2025 | 3698 | 0.030 |
Why?
|
| Electrocoagulation | 1 | 2017 | 32 | 0.030 |
Why?
|
| Ophthalmologic Surgical Procedures | 1 | 2018 | 78 | 0.030 |
Why?
|
| Prognosis | 1 | 2007 | 5008 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2025 | 3873 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2020 | 14718 | 0.030 |
Why?
|
| Bronchoscopy | 1 | 2017 | 174 | 0.030 |
Why?
|
| Cerebral Hemorrhage | 1 | 2017 | 158 | 0.030 |
Why?
|
| Software | 1 | 2001 | 729 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2025 | 5150 | 0.030 |
Why?
|
| Tracheostomy | 1 | 2017 | 201 | 0.030 |
Why?
|
| Acute Disease | 1 | 2018 | 1161 | 0.030 |
Why?
|
| Respiration, Artificial | 1 | 2017 | 501 | 0.030 |
Why?
|
| Intubation, Intratracheal | 1 | 2017 | 288 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2022 | 17374 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2022 | 1997 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2025 | 7119 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2022 | 5399 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2001 | 1063 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 3738 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2013 | 198 | 0.020 |
Why?
|
| Pregnancy | 1 | 2005 | 7551 | 0.020 |
Why?
|
| Brain Neoplasms | 1 | 2022 | 1411 | 0.020 |
Why?
|
| Intestinal Obstruction | 1 | 2013 | 96 | 0.020 |
Why?
|
| Constriction, Pathologic | 1 | 2012 | 235 | 0.020 |
Why?
|
| Survival Rate | 1 | 2017 | 2186 | 0.020 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2013 | 237 | 0.020 |
Why?
|
| Diarrhea | 1 | 2013 | 329 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 3083 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2012 | 486 | 0.020 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2010 | 56 | 0.020 |
Why?
|
| Registries | 1 | 2017 | 1589 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2025 | 13017 | 0.020 |
Why?
|
| Adolescent | 1 | 2007 | 20532 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2020 | 4725 | 0.020 |
Why?
|
| Risk Factors | 1 | 2022 | 10902 | 0.020 |
Why?
|
| Infant | 1 | 2020 | 13039 | 0.010 |
Why?
|
| Young Adult | 1 | 2017 | 9940 | 0.010 |
Why?
|